Biovail Corp.

Mr. Wells is our Chief Executive Officer and President of Biovail Laboratories International SRL, positions he has held since May 1, 2008. Mr. Wells was elected to the Board of Directors in June 2005. Mr. Wells served as the Lead Director of the Board from June 30, 2007 to April 18, 2008. Prior to joining us on May 1, 2008, Mr. Wells was the Chief Financial Officer of Loblaw Companies Limited, Canada's largest food distributor and a leading provider of general merchandise products, drugstore products, and financial products and services a position from which he resigned immediately prior to joining Biovail as our Chief Executive Officer. Mr. Wells also served as a director or officer of a number of subsidiaries of Loblaw. Prior to his position at Loblaw, Mr. Wells served as Chief Financial Officer of Bunge Limited, a U.S.-headquartered company, whose shares are listed on the NYSE, in the global agribusiness, fertilizer and food product industries, and has served as a director or officer of a number of other subsidiaries and joint ventures of Bunge since January 2000. Mr. Wells is versed in corporate governance matters, having led Bunge's initial public offering on the NYSE, managed its SOX compliance process and overseen its investor relations program. Prior to joining Bunge, Mr. Wells spent ten years in senior financial management at McDonald's Corporation in theU.S. and Brazil. Mr. Wells is currently a Trustee and a member of the audit committee of the Lakefield College School Foundation, a member of the investment committee of the Uruguay International Venture Capital Fund and formerly a member of the Standard & Poor's Corporate Issuer Advisory Board. Mr. Wells is a member of our Risk and Compliance Committee. Mr. Wells is based in Barbados.

As Executive Vice-President, COO, Gilbert Godin oversees Biovail's operational functions, product-development capability, manufacturing and contract-development services, as well as business-development services. He joined Biovail in April 2006 as Senior Vice-President, Technical Operations/Drug Delivery. Mr. Godin came to Biovail from MDS Pharma Services, where he held a series of progressively responsible executive positions in Canada and the United States. From October 2004, he served as President of MDS Pharma, a contract research organization that provides drug-discovery and development services to pharmaceutical and biotechnology companies. Before joining MDS in 1999, Mr. Godin spent eight years with Schering Plough, where he held the technical leadership position in Canada, and a business-unit management role in France . He has also held several positions with business and operational accountabilities during his seven-year tenure at L'Oreal Canada. Mr. Godin has a Masters degree in Business Administration from Concordia University in Montreal. He also holds an engineering degree from Sherbrooke University in Quebec.

As Senior Vice-President, Human Resources & Shared Services, Mark Durham oversees Biovail's Human Resources, internal communications, procurement and office-based facilities functions. Mr. Durham joined Biovail as Vice-President, Corporate Human Resources in 2003. He came to Biovail from Pharmacia Corporation, where he served as Vice-President, Human Resources for Global Marketing and North American country operations from 2000-2003. Previously, he spent 15 years with Pharmacia and Upjohn, and held senior Human Resources positions in the United States, Asia and Canada. In addition to Human Resources, Mr. Durham has held positions in Manufacturing and Sales Operations. Mr. Durham holds a B.A. Hons. degree in Political Science and Economics from Carleton University in Ottawa.

Peggy Mulligan serves as Senior Vice-President and Chief Financial Officer (CFO) of Biovail Corporation. As such, Mrs. Mulligan oversees all of Biovail's financial operations, and is responsible for Internal Audit and Information Technology. Mrs. Mulligan was most recently a Principal at Priiva Consulting Corporation, a leading game theory consulting practice. Prior to that, she served as Executive Vice-President, Chief Financial Officer and Treasurer of Linamar Corporation from 2005 to 2007. Prior to Linamar, Mrs. Mulligan spent more than eleven years with The Bank of Nova Scotia (Scotiabank), most recently as Executive Vice-President, Systems and Operations, where she was responsible for operational processes and technology across Canada and in more than 50 other markets. She directed a staff of over 3,000 and managed a broad range of critical information-technology functions. Earlier in her career at Scotiabank, Mrs. Mulligan served as Senior Vice-President, Audit & Chief Inspector. Before joining Scotiabank, Mrs. Mulligan was an Audit Partner with PricewaterhouseCoopers in Toronto . Mrs. Mulligan currently serves on the boards of Ontario Power Generation Inc. and Resolve Business Outsourcing Income Fund. Her extensive community involvement has included serving as a Trustee of the Ontario Science Centre, a Governor of Appleby College and a Governor of the University of Waterloo. Mrs. Mulligan holds a B.Math (Honours) from the University of Waterloo and was named a Fellow Chartered Accountant (FCA) by the Institute of Chartered Accountants of Ontario in 2003.

As Senior Vice-President, Business Development Services, Biovail Pharmaceuticals, Inc. Christine Mayer is responsible for leading the Business Development Services team, which provides services in respect of identifying and analyzing new opportunities for the Company. Ms. Mayer joined Biovail in May 2005, and was promoted to her current title effective January 1, 2007. She has over 20 years of broad business experience in the pharmaceutical industry across many disciplines and therapeutic areas. Before joining Biovail, she held the position of Vice-President of Global Business Development at Sanofi-Aventis (formerly Aventis), where she spent five years. Prior to that, she worked for 13 years at Johnson & Johnson in the pharmaceutical sector, holding many positions in various disciplines, including Business Development, Marketing, Sales and Finance. Ms. Mayer also has four years of previous experience in large public accounting firms. Ms. Mayer holds an M.B.A. from Rutgers University and a B.A. from Glassboro College.

As Senior Vice-President, Corporate Development, Biovail Corporation, Greg Gubitz investigates growth opportunities and other initiatives that will enable Biovail to maximize the value of current and future investments. He also assists the Company in the strategic-planning process. Mr. Gubitz joined Biovail in March 2006 from MDS Capital Corp., a North American venture-capital company focused exclusively on life sciences, where he was Chief Operating Officer. He spent 10 years with MDS Capital in various senior roles, with accountability for all operational matters, institutional fund-raising, investor relations, finance and legal affairs. Mr. Gubitz also became Chairman of MDS Capital's Investment Committee in 2004. Before joining MDS Capital in 1996, Mr. Gubitz was a partner practising corporate and securities law at Fasken, Martineau Barristers and Solicitors. He was called to the Bar in the Province of Ontario in 1984. Mr. Gubitz holds an LL.B. and a Bachelor of Arts degree from McGill University in Montreal.

As Senior Vice-President, General Counsel and Corporate Secretary, Wendy Kelley is a member of Biovail's senior management team. She is responsible for Biovail's worldwide legal operations, including corporate governance, securities compliance, mergers and acquisitions, intellectual property, litigation, patent law and legal policies. She also serves as Corporate Secretary to the Board of Directors. Prior to joining Biovail in August 2006, Ms. Kelley was Vice-President, Associate General Counsel and Principal Reputation Risk Officer for BMO Financial Group. Her responsibilities included enterprise-wide responsibility for corporate governance; legal and reputation risk management; regulatory relationship management; and management of all securities litigation and regulatory enforcement issues. Previously, she served as Managing Director and Associate General Counsel for BMO Nesbitt Burns, the broker-dealer and wealth-management firm of BMO Financial Group, where she oversaw all litigation, securities policy development and regulatory enforcement, including management of several large international securities class actions. Previously, she was a lawyer at Torys, LLP, an international law firm. Ms. Kelley received her law degree from Queen's University, Canada and is a graduate of the Advanced Management Program from Harvard Business School.

Dr. Squires is the Chairman of the Board. Dr. Squires has served on our Board of Directors since June 29, 2005. From June 30, 2007 to May 1, 2008, Dr. Squires served as Interim Chairman of the Board. Effective May 1, 2008, Dr. Squires was appointed Chairman of the Board. From November 2004 to May 1, 2008, Dr. Squires was our Chief Executive Officer. Before joining Biovail in November 2004, Dr. Squires spent six years at MDS Inc, a publicly traded company on the NYSE and the TSX, the last three as President and Chief Executive Officer of MDS Pharma Services, which provides drug-discovery and development services to pharmaceutical and biotechnology companies. Before joining MDS, Dr. Squires spent more than 22 years with The Upjohn Company and Pharmacia Upjohn Inc., where he held multiple senior positions inCanada, the United States and the Pacific Rim. He received his B.Sc. from the University of Toronto and his Ph.D. in biophysics from the University of London, Institute of Cancer Research.

David Laidley was elected to the Board of Directors in August 2008. Mr. Laidley is a retired partner of Deloite & Touche LLP and served as Chairman of Deloite & Touche LLP from 2000 to 2006. Mr. Laidley is also a director of the Bank of Canada, Aviva Canada Inc., EMCOR Group, Inc., Groupe Aeroplan Inc., ProSep Inc. and is Chairman of Nautilus Indemnity Holdings Limited (Bermuda), a captive insurance company. Mr. Laidley also serves on the boards of the Fraser Institute, the Institute of Corporate Directors, and Pearson College of the Pacific. Mr. Laidley is a Fellow of the Quebec Order of Chartered Accountants and holds a Bachelor of Commerce degree from McGill University. Mr. Laidley is a member of our Nominating and Corporate Governance Committee and a member of our Audit Committee.

"J. Spencer Lanthier is a distinguished board member and contributor with some of Canada's leading corporations and community organizations. He joined Zarlink's Board of Directors in May 2003. Mr. Lanthier enjoyed a 39-year career with KPMG Canada, serving as Chairman and CEO of the firm's Canadian operations from 1993 until he retired in 1999. Financial Post Magazine repeatedly named him one of Canada's Top 200 CEOs. A recipient of the Order of Canada, Mr. Lanthier is currently a Director of the Boards of the TSX Group, Inc., Bank of Canada, Torstar Corporation, Ellis-Don Inc., BCE Emergis, Gerdau Ameristeel Inc. and Biovail. He is also active with the United Way, Goodwill Industries, The University of Toronto, and the London Health Sciences Foundation. Educated at McGill University, Mr. Lanthier received an honorary Doctor of Law from the University of Toronto in 2002. "

Jamie C. Sokalsky assumed the responsibilities of Executive Vice President and Chief Financial Officer of Barrick Gold Corporation in May 2004. Previously, Mr. Sokalsky had been the Senior Vice President and Chief Financial Officer since March 1999 and Vice President and Treasurer, directing the financial operations of the Company including the successful forward sales program, for six years. Mr. Sokalsky has an Honours Bachelor of Commerce degree from Lakehead University, Ontario and received his chartered accountant designation in 1982.

Mark Parrish was elected to the Board of Directors in August 2008. Mr. Parrish serves as Chairman and Chief Executive Officer of Mobilex USA and Diagnostic Laboratories, a privately held Long-Term Care services company providing Mobile X-Ray and Laboratory services to Skilled Nursing Facilities nationwide. Additionally, Mr. Parrish is the President of the International Federation of Pharmaceutical Wholesalers and a Senior Advisor, Growth Equity at Frazier Healthcare Ventures. Mr. Parrish was Chief Executive Officer of Healthcare Supply Chain Services for Cardinal Health Inc., an $87 billion global manufacturer and distributor of medical and surgical supplies and technologies, publicly traded on the NYSE, from November 2006 to 2007. Cardinal Health?s customers are located on five continents and include hospitals, medical centers, retail and mail-order pharmacies, clinics, physicians, pharmacists and other healthcare providers. Mr. Parrish also served in a number of other roles at Cardinal Health Inc., including as Group President, Pharmaceutical Supply Chain Services from August 2006, President and Chief Operating Officer, Pharmaceutical Supply Chain Services from September 2005 to August 2006, Chairman and Chief Executive Officer, Pharmaceutical Distribution and Provider Services from August 2004 to September 2005, Executive Vice President and Group President, Pharmaceutical Distribution from January 2003 to August 2004 and President, Medicine Shoppe, a subsidiary of Cardinal Health Inc., from July 2001 to January 2003. Mr. Parrish holds a Bachelor of Arts degree from the University of California, Berkley. Mr. Parrish is the Chairperson of our Risk and Compliance Committee and a member of our Compensation Committee.

Michael Van Every was elected to the Board of Directors in June 2004. Mr. Van Every is a retired partner of PricewaterhouseCoopers LLP. From 1969 to 1998, he was a partner of Coopers & Lybrand, one of the predecessor firms of PricewaterhouseCoopers LLP. During that period, he served for various periods as Partner in Charge of an office, a member of the Management Committee, a member of the Partnership Board and Chair of the Partnership Audit and Governance Committees. Mr. Van Every is also a member of the boards of Kelman Technologies Inc. (a TSX-listed company) and the Jockey Club of Canada. Mr. Van Every has completed the Director Education Program sponsored by the Rotman School of Management and the Institute of Corporate Directors, and has received his ICD.D, the professional designation for directors in Canada. Mr. Van Every is Chairperson of our Audit Committee and a member of our Risk and Compliance Committee.

ROBERT A. PAUL (age 71, Director since 1970). Mr. Paul has been Chairman and Chief Executive Officer since March 2004. Prior to March 2004, he was President and Chief Executive Officer of the Corporation for more than five years. He is also the President and a director of The Louis Berkman Investment Company.

Robert N. Power was elected to the Board of Directors in August 2008. Mr. Power was most recently the Executive Vice President of Global Business Operations of Wyeth, a global leader in prescription pharmaceuticals, non-prescription consumer health care products, and pharmaceuticals for animal health, which is publicly traded on the NYSE. Wyeth's product portfolio includes innovative treatments across a wide range of therapeutic areas, manufacturing facilities on four continents, and a unique research and technology base encompassing small molecules, biopharmaceuticals and vaccines. Mr. Power has held a number of leadership positions with Wyeth Pharmaceuticals since 1985 including Managing Director U.K., President EMEA and President International. Mr. Power holds a Masters of Science (Biostatistics) degree from the Medical College of Virginia and a Bachelor of Arts (Statistics) degree from S.U.N.Y Oneonta. Mr. Power is a member of our Compensation Committee and a member of our Risk and Compliance Committee.

Serge Gouin was elected to the Board of Directors in August 2008. Mr. Gouin is Chairman of Quebecor Media Inc., a communications, media and entertainment company. From March 2004 to May 2005, Mr. Gouin was President and Chief Executive Officer of Quebecor Media Inc. In the past five years, Mr. Gouin was also Vice Chairman, Salomon Smith Barney Canada, Inc., a financial services company, until 2003, and advisory director of Citigroup Global Markets Canada Inc., a financial services company, from 2003 to 2004. Mr. Gouin serves as a director of TVA Group Inc., a broadcast communications company, and Chairman of the board of directors of Sun Media Corporation, a newspaper publishing company, and Videotron Limited, a cable television company, all of which are part of the Quebecor group of companies. Mr. Gouin is also a director of Onex Corporation, a conglomerate publicly traded on the TSX. He also serves on the Advisory Committee of the Richard Ivey School of Business. Mr. Gouin holds a Bachelor of Arts degree from the University of Montreal, as well as a Bachelor of Arts degree and Master of Business Administration degree from the Ivey School of Business. Mr. Gouin is a member of our Audit Committee and a member of our Nominating and Corporate Governance Committee.